Effects of konjac glucomannan on blood profile in schizophrenia with hyperglycemia
Pra eksperimental study
Keywords:
a new therapeutic method herb, blood profile, konjac glukomannan, pra eksperimental, schizophreniaAbstract
Background and Objectives: Konjac glucomannan has the effect of maintaining Blood Glukosa Fasting (BGF) in the general population, but there is no research on schizophrenic patients who are susceptible to hyperglycemia. Our study aims to evaluate the effects of konjac glucomannan on blood glucose levels in schizophrenia in patients with hyperglycemia. Methods and Study Design: eight people with schizophrenia were enrolled in a 30-day pra experimental study. The subjects in the experimental group were given a capsule containing konjac glucomannan 30 minutes before each meal Results: The plasma glucose was measured at baseline and at the first of 0-day treatment end of 31-day treatment. Eight subjects completed the study. There was a substantial decrease in plasma glucose in the experimental group. Conclusions: We concluded that a diet supplemented with konjac glucomannan may prevent the deterioration of hyperglycemia in people with schizophrenia, demonstrating its potential value in the treatment of metabolic disorders in schizophrenia as a new therapeutic method herb.
Downloads
References
Anderson, J. W., Baird, P., Davis, R. H., Ferreri, S., Knudtson, M., Koraym, A., ... & Williams, C. L. (2009). Health benefits of dietary fiber. Nutrition reviews, 67(4), 188-205.
Baller, J. B., McGinty, E. E., Azrin, S. T., Juliano-Bult, D., & Daumit, G. L. (2015). Screening for cardiovascular risk factors in adults with serious mental illness: a review of the evidence. BMC psychiatry, 15(1), 1-13.
Bernardo, M., Rico-Villademoros, F., García-Rizo, C., Rojo, R., & Gómez-Huelgas, R. (2021). Real-world data on the adverse metabolic effects of second-generation antipsychotics and their potential determinants in adult patients: a systematic review of population-based studies. Advances in therapy, 38(5), 2491-2512.
Castro-Barquero, S., Ruiz-León, A. M., Sierra-Pérez, M., Estruch, R., & Casas, R. (2020). Dietary strategies for metabolic syndrome: a comprehensive review. Nutrients, 12(10), 2983.
Dwirahayu, Y., & Mashudi, S. (2016). Nicotine effect toward the oocyte level of rats (Rattus novergicus). Asian Pacific Journal of Reproduction, 5(6), 495-499. https://doi.org/10.1016/j.apjr.2016.10.005
Eckel, R. H., Jakicic, J. M., Ard, J. D., de Jesus, J. M., Houston Miller, N., Hubbard, V. S., ... & Yanovski, S. Z. (2014). 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American college of cardiology, 63(25 Part B), 2960-2984.
Gilbert-Jaramillo, J., Vargas-Pico, D., Espinosa-Mendoza, T., Falk, S., Llanos-Fernández, K., Guerrero-Haro, J., ... & Palmer, C. (2018). The effects of the ketogenic diet on psychiatric symptomatology, weight and metabolic dysfunction in schizophrenia patients. Clinical Nutrition and Metabolism, 1, 1-5.
Jenkins, D. J., Axelsen, M., Kendall, C. W., Augustin, L. S., Vuksan, V., & Smith, U. (2000). Dietary fibre, lente carbohydrates and the insulin-resistant diseases. British Journal of Nutrition, 83(S1), S157-S163.
Julibert, A., Bibiloni, M. D. M., Bouzas, C., Martínez-González, M. Á., Salas-Salvadó, J., Corella, D., ... & Predimed-Plus Investigators. (2019). Total and subtypes of dietary fat intake and its association with components of the metabolic syndrome in a mediterranean population at high cardiovascular risk. Nutrients, 11(7), 1493.
Kelly, J. R., Gounden, P., McLoughlin, A., Legris, Z., O’Carroll, T., McCafferty, R., ... & Dolan, C. (2022). Minding metabolism: targeted interventions to improve cardio-metabolic monitoring across early and chronic psychosis. Irish Journal of Medical Science (1971-), 191(1), 337-346.
Mashudi, S. (2017). Genetic And Genomic Nursing Competencies For The Community Nurse. In A. C. H. Sri Sumarmi, Ika Yuni Widyawati, Trias Mahmudiono, Triska Susila N, Maya Sari Dewi (Ed.), 1st International Symposium of Public Health " Emerging and Re-emerging Diseases (1st ed.). S3 Ilmu Kesehatan FKM Unair.
Mashudi, S. (2019). Kesehatan Keluarga penderita Ganggua Jiwa (1st ed.). UM POnorogo Press.
Mashudi, S. (2020). Diet Ketogenik: Strategi Baru Penanganan Penderita Skizofrenia. Collaborative Medical Journal (CMJ), 3(3), 99-103.
Mashudi, S., & Okviana Armyati, E. (2021). Paradigma Baru Penanganan Skizofrenia Perspsektif Nurtrigenomik.
Mashudi, S., & Yusuf, A. (2021). Family Coping Strategies to Improve the Health of Family Members Living with Schizophrenia. Jurnal Ners, 16(1), 67-73.
Mashudi, S., Yusuf, A., Triyoga, R. S., Kusnanto, K., & Suhron, M. (2019). The Burden in Providing Caregiving Service to Mentally Illed Patients in Ponorogo. Indian Journal of Public Health Research and Development, 10(10), 1113-1117.
McRae, M. P. (2020). Effectiveness of Fiber Supplementation for Constipation, Weight Loss, and Supporting Gastrointestinal Function: A Narrative Review of Meta-Analyses. Journal of Chiropractic Medicine, 19(1), 58-64. https://doi.org/10.1016/j.jcm.2019.10.008
Mitchell, A. J., Vancampfort, D., Sweers, K., van Winkel, R., Yu, W., & De Hert, M. (2013). Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders—a systematic review and meta-analysis. Schizophrenia bulletin, 39(2), 306-318.
Palmer, C. M., Gilbert-Jaramillo, J., & Westman, E. C. (2019). The ketogenic diet and remission of psychotic symptoms in schizophrenia: Two case studies. Schizophrenia research, 208, 439-440.
Sood, N., Baker, W. L., & Coleman, C. I. (2008). Effect of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis. The American journal of clinical nutrition, 88(4), 1167-1175.
Tucker, L. A. (2018). Fiber intake and insulin resistance in 6374 adults: The role of abdominal obesity. Nutrients, 10(2), 237.
Tucker, L. A., & Thomas, K. S. (2009). Increasing total fiber intake reduces risk of weight and fat gains in women. The Journal of Nutrition, 139(3), 576–581.
Vuksan, V., Sievenpiper, J. L., Owen, R., Swilley, J. A., Spadafora, P., Jenkins, D. J., Vidgen, E., Brighenti, F., Josse, R. G., Leiter, L. A., Xu, Z., & Novokmet, R. (2000). Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial. Diabetes Care, 23(1), 9–14.
Zhang, L., Han, Y., Zhao, Z., Liu, X., Xu, Y., Cui, G., Zhang, X., & Zhang, R. (2020). Beneficial effects of konjac powder on lipid profile in schizophrenia with dyslipidemia: A randomized controlled trial. Asia Pacific Journal of Clinical Nutrition, 29(3), 505–512.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
